Four immunoassays for neurofilament light chain show consistent performance in amyotrophic lateral sclerosis

by

Four immunoassays for neurofilament light chain (NfL) demonstrate consistent performance in patients with amyotrophic lateral sclerosis (ALS), with high diagnostic and prognostic accuracy, according to a study published online Feb. 26 in Neurology.

Leave A Comment

Your email address will not be published. Required fields are marked *